100 related articles for article (PubMed ID: 10022133)
1. Accelerated accumulation of somatic mutations in mice deficient in the nucleotide excision repair gene XPA.
Giese H; Dollé ME; Hezel A; van Steeg H; Vijg J
Oncogene; 1999 Feb; 18(5):1257-60. PubMed ID: 10022133
[TBL] [Abstract][Full Text] [Related]
2. p53 heterozygosity results in an increased 2-acetylaminofluorene-induced urinary bladder but not liver tumor response in DNA repair-deficient Xpa mice.
Hoogervorst EM; van Oostrom CT; Beems RB; van Benthem J; Gielis S; Vermeulen JP; Wester PW; Vos JG; de Vries A; van Steeg H
Cancer Res; 2004 Aug; 64(15):5118-26. PubMed ID: 15289314
[TBL] [Abstract][Full Text] [Related]
3. Effect of heterozygous loss of p53 on benzo[a]pyrene-induced mutations and tumors in DNA repair-deficient XPA mice.
van Oostrom CT; Boeve M; van Den Berg J; de Vries A; Dollé ME; Beems RB; van Kreijl CF; Vijg J; van Steeg H
Environ Mol Mutagen; 1999; 34(2-3):124-30. PubMed ID: 10529736
[TBL] [Abstract][Full Text] [Related]
4. Mutation spectrum in UVB-exposed skin epidermis of Xpa-knockout mice: frequent recovery of triplet mutations.
Ikehata H; Yanase F; Mori T; Nikaido O; Tanaka K; Ono T
Environ Mol Mutagen; 2007 Jan; 48(1):1-13. PubMed ID: 17163503
[TBL] [Abstract][Full Text] [Related]
5. Role of nucleotide excision repair deficiency in intestinal tumorigenesis in multiple intestinal neoplasia (Min) mice.
Steffensen IL; Schut HA; Nesland JM; Tanaka K; Alexander J
Mutat Res; 2006 Dec; 611(1-2):71-82. PubMed ID: 16962818
[TBL] [Abstract][Full Text] [Related]
6. Mice deficient in the nucleotide excision repair gene XPA have elevated sensitivity to benzo[a]pyrene induction of lung tumors.
Ide F; Iida N; Nakatsuru Y; Oda H; Tanaka K; Ishikawa T
Carcinogenesis; 2000 Jun; 21(6):1263-5. PubMed ID: 10837020
[TBL] [Abstract][Full Text] [Related]
7. Elevated frequencies of benzo(a)pyrene-induced Hprt mutations in internal tissue of XPA-deficient mice.
Bol SA; van Steeg H; Jansen JG; Van Oostrom C; de Vries A; de Groot AJ; Tates AD; Vrieling H; van Zeeland AA; Mullenders LH
Cancer Res; 1998 Jul; 58(13):2850-6. PubMed ID: 9661901
[TBL] [Abstract][Full Text] [Related]
8. Cell-type-specific consequences of nucleotide excision repair deficiencies: Embryonic stem cells versus fibroblasts.
de Waard H; Sonneveld E; de Wit J; Esveldt-van Lange R; Hoeijmakers JH; Vrieling H; van der Horst GT
DNA Repair (Amst); 2008 Oct; 7(10):1659-69. PubMed ID: 18634906
[TBL] [Abstract][Full Text] [Related]
9. Mouse models for xeroderma pigmentosum group A and group C show divergent cancer phenotypes.
Melis JP; Wijnhoven SW; Beems RB; Roodbergen M; van den Berg J; Moon H; Friedberg E; van der Horst GT; Hoeijmakers JH; Vijg J; van Steeg H
Cancer Res; 2008 Mar; 68(5):1347-53. PubMed ID: 18316597
[TBL] [Abstract][Full Text] [Related]
10. The relationship between benzo[a]pyrene-induced mutagenesis and carcinogenesis in repair-deficient Cockayne syndrome group B mice.
Wijnhoven SW; Kool HJ; van Oostrom CT; Beems RB; Mullenders LH; van Zeeland AA; van der Horst GT; Vrieling H; van Steeg H
Cancer Res; 2000 Oct; 60(20):5681-7. PubMed ID: 11059760
[TBL] [Abstract][Full Text] [Related]
11. Phenacetin acts as a weak genotoxic compound preferentially in the kidney of DNA repair deficient Xpa mice.
Luijten M; Speksnijder EN; van Alphen N; Westerman A; Heisterkamp SH; van Benthem J; van Kreijl CF; Beems RB; van Steeg H
Mutat Res; 2006 Apr; 596(1-2):143-50. PubMed ID: 16464479
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of nucleotide excision repair by anti-XPA monoclonal antibodies which interfere with binding to RPA, ERCC1, and TFIIH.
Saijo M; Matsuda T; Kuraoka I; Tanaka K
Biochem Biophys Res Commun; 2004 Sep; 321(4):815-22. PubMed ID: 15358100
[TBL] [Abstract][Full Text] [Related]
13. Suppression of UV carcinogenesis by difluoromethylornithine in nucleotide excision repair-deficient Xpa knockout mice.
Rebel H; van Steeg H; Beems RB; Schouten R; de Gruijl FR; Terleth C
Cancer Res; 2002 Mar; 62(5):1338-42. PubMed ID: 11888902
[TBL] [Abstract][Full Text] [Related]
14. Severe growth retardation and short life span of double-mutant mice lacking Xpa and exon 15 of Xpg.
Shiomi N; Mori M; Kito S; Harada YN; Tanaka K; Shiomi T
DNA Repair (Amst); 2005 Mar; 4(3):351-7. PubMed ID: 15661658
[TBL] [Abstract][Full Text] [Related]
15. Age-dependent spontaneous mutagenesis in Xpc mice defective in nucleotide excision repair.
Wijnhoven SW; Kool HJ; Mullenders LH; van Zeeland AA; Friedberg EC; van der Horst GT; van Steeg H; Vrieling H
Oncogene; 2000 Oct; 19(43):5034-7. PubMed ID: 11042691
[TBL] [Abstract][Full Text] [Related]
16. A truncated human xeroderma pigmentosum complementation group A protein expressed from an adenovirus sensitizes human tumor cells to ultraviolet light and cisplatin.
Rosenberg E; Taher MM; Kuemmerle NB; Farnsworth J; Valerie K
Cancer Res; 2001 Jan; 61(2):764-70. PubMed ID: 11212280
[TBL] [Abstract][Full Text] [Related]
17. 2-AAF-induced tumor development in nucleotide excision repair-deficient mice is associated with a defect in global genome repair but not with transcription coupled repair.
Hoogervorst EM; van Oostrom CT; Beems RB; van Benthem J; van den Berg J; van Kreijl CF; Vos JG; de Vries A; van Steeg H
DNA Repair (Amst); 2005 Jan; 4(1):3-9. PubMed ID: 15533832
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous liver tumors and benzo[a]pyrene-induced lymphomas in XPA-deficient mice.
de Vries A; van Oostrom CT; Dortant PM; Beems RB; van Kreijl CF; Capel PJ; van Steeg H
Mol Carcinog; 1997 May; 19(1):46-53. PubMed ID: 9180928
[TBL] [Abstract][Full Text] [Related]
19. Induction of DNA adducts and mutations in spleen, liver and lung of XPA-deficient/lacZ transgenic mice after oral treatment with benzo[a]pyrene: correlation with tumour development.
de Vries A; Dollé ME; Broekhof JL; Muller JJ; Kroese ED; van Kreijl CF; Capel PJ; Vijg J; van Steeg H
Carcinogenesis; 1997 Dec; 18(12):2327-32. PubMed ID: 9450477
[TBL] [Abstract][Full Text] [Related]
20. XPA-deficiency in hairless mice causes a shift in skin tumor types and mutational target genes after exposure to low doses of U.V.B.
de Vries A; Berg RJ; Wijnhoven S; Westerman A; Wester PW; van Kreijl CF; Capel PJ; de Gruijl FR; van Kranen HJ; van Steeg H
Oncogene; 1998 Apr; 16(17):2205-12. PubMed ID: 9619829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
